Appeals Board ruling puts Centriq–Dis-Chem partnership on the line

In Circular 48, the CMS signals tougher enforcement against exempted insurers, warning that non-compliant branding and failure to notify regulators will attract decisive action.

Read More

Key compliance issues for FSPs in 2025/26

Mark Bechard talks to Billy Seyffert, Moonstone Compliance’s chief operating officer, about regulatory developments shaping the compliance landscape. Billy provides his views on the OMNI-Risk Return – why it’s better than the OMNI-CBR […]

Read More